鉄の調節不全とフェロプトーシスは肺線維症と関連している.イディオパシー肺線維症,全身性硬化症,COVID-19患者からの洞察
PubMedで要約を見る
まとめ
この要約は機械生成です。鉄過負荷とフェロプトーシスは,COVID-19および全身性硬化症に関連するPFを含む肺線維症 (PF) で一般的です. 肺細胞とマクロファージで特に顕著なこれらのプロセスは,PFの有望な治療目標を表しています.
科学分野
- 肺医学
- 細胞生物学
- 免疫学
背景
- 肺線維症 (PF) は主要な死因であり,しばしば炎症と組織損傷に関連しています.
- 様々なPF疾患における鉄代謝とフェロプトーシスの役割は完全に理解されていません.
- 異なるタイプのPFにおける鉄の役割の研究は,病気のメカニズムを理解するために不可欠です.
研究 の 目的
- 鉄代謝とフェロプトーシスシグネチャをイディオパシー性肺線維症 (IPF),全身性硬化症関連PF (SSc-PF),COVID-19と比較する.
- PFにおける鉄過負荷とフェロプトーシスを標的とした細胞の局所化と治療の可能性を調査する.
- 公開データセットと in vitro/in vivo モデルを用いて調査結果を検証する.
主な方法
- IPF,SSc-PF,COVID-19患者のサンプルにおける鉄濃度 (パルスの染色,フェリチン) とフェロプトーシスマーカー (MDA,4HNE,GPX4,FSP1) の比較分析.
- 免疫ヒスト化学,伝送電子顕微鏡,およびフェロプトーシス検出のための公開データセット分析.
- デフェロキサミン (DFO) とフェロスタチン-1 (Fer1) で鉄媒介性炎症と線維症を評価するSARS-CoV-2スパイクタンパク質誘発型PFを用いたインビトロおよびインビボ試験.
主要な成果
- COVID-19は最も重度の肺損傷と線維症を示した.
- 鉄の過剰負荷とフェロプトーシスは,IPF,SSc-PF,COVID-19において,異なる鉄代謝プロファイル (高いHO-1) で流行していた.
- 鉄過負荷とフェロプトーシスは主にアルベオラ型II細胞とマクロファージで発生した. DFOとFer1の治療は,体内において線維症と炎症マーカー (MDA,IL-6) を減少させた.
結論
- 鉄過負荷とフェロプトーシスは,様々な形態の肺線維症における一般的な病理的特徴である.
- 鉄代謝とフェロプトーシス経路をターゲットにすることは,肺線維症の潜在的な治療戦略を提供します.
- これらの発見は,PFの病原性における鉄依存性細胞死亡の保存された役割を強調しています.
関連する概念動画
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
• Chronic Cough: A persistent cough, often productive, is a crucial symptom of COPD.
•...
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...

